For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Easy-to-understand resources to improve medicine safety
Wednesday 26 May 2021, 01:40 AM

John Robson, chief clinical officer & head of health partnerships, ACC, with Health Navigator's Jeremy Steinberg, Janine Bycroft and Sandra Ponen
ACC PATIENT SAFETY AWARD
This award celebrates excellence in safe practice. It recognises an individual or team for outstanding innovation and leadership in patient safety, and raises awareness and support for the safety of all patients in all healthcare settings
WINNER
IMPROVING MEDICINE SAFETY
Health Navigator Charitable Trust
Adverse drug events or reactions are major causes of patient morbidity and m
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.